Drugs / RVF MP-12
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00415051 | Aug 2006 → May 2008 | Rift valley fever | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RVF MP-12 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00415051 ↗ |
| Modality | Vaccine | “a vaccine for Rift Valley Fever (RVF)” NCT00415051 ↗ |
| Route | Intramuscular | “an intramuscular (IM) injection of live, attenuated, mutagenized RVF 12th mutagenesis passage (MP-12) vaccine” NCT00415051 ↗ |